Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metacognitive Therapy for Obsessive-Compulsive Disorder
Sponsor: Northeast Normal University
Summary
The goal of this clinical trial is to learn if metacognitive therapy can be effective in a Chinese sample of obsessive compulsive disorder (OCD) . The main questions it aims to answer are: Can metacognitive therapy significantly reduce participants' levels of obsessive-compulsive symptoms? Can metacognitive therapy significantly improve participants' metacognitive adaptations? The researchers will compare metacognitive therapy to a control condition without psychotherapy to see if metacognitive therapy is effective in treating OCD. Participants will: Receive the metacognitive therapy intervention or under control conditions for 8 to 15 weeks. Be assessed for symptoms and metacognitive beliefs at pre-intervention, post-intervention and 12 weeks post-intervention
Official title: The Efficacy of Metacognitive Therapy for Obsessive-compulsive Disorder
Key Details
Gender
All
Age Range
12 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-06-11
Completion Date
2024-11-01
Last Updated
2024-06-20
Healthy Volunteers
No
Conditions
Interventions
Metacognitive Therapy
A one-on-one face-to-face dialogue format will be used to conduct psychotherapy with each participant, and the treatment protocol will be based on the treatment manual for metacognitive therapy.
General mental health promotion
A general mental health mission will be conducted, not covering any metacognitive therapy related content, set for 8-15 weeks, 1 time per week
Locations (1)
Northeast Normal University
Changchun, Jilin, China